Daesung Microbiological Labs. Co. Ltd (036480) — Cash Flow-to-Debt Ratio
Daesung Microbiological Labs. Co. Ltd (036480) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩972.26 Million could theoretically repay 0% of its total liabilities (₩22.56 Billion) in one year. See 036480 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Daesung Microbiological Labs. Co. Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Daesung Microbiological Labs. Co. Ltd across 14 annual periods. Also explore 036480 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year debt coverage analysis for Daesung Microbiological Labs. Co. Ltd. For market capitalisation and broader financial context, see market cap of Daesung Microbiological Labs. Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩1.41 Billion | ₩22.56 Billion | ▼ -31.0% |
| 2024 | 0.09x | ₩2.10 Billion | ₩23.23 Billion | ▲ +297.7% |
| 2023 | -0.05x | ₩-1.23 Billion | ₩26.94 Billion | ▼ -204.1% |
| 2022 | 0.04x | ₩1.16 Billion | ₩26.27 Billion | ▼ -48.9% |
| 2021 | 0.09x | ₩2.20 Billion | ₩25.62 Billion | ▼ -31.0% |
| 2020 | 0.12x | ₩3.24 Billion | ₩25.95 Billion | ▼ -15.6% |
| 2019 | 0.15x | ₩2.32 Billion | ₩15.68 Billion | ▼ -76.0% |
| 2018 | 0.62x | ₩3.14 Billion | ₩5.09 Billion | ▲ +64.5% |
| 2017 | 0.37x | ₩1.68 Billion | ₩4.49 Billion | ▼ -29.8% |
| 2016 | 0.53x | ₩3.52 Billion | ₩6.60 Billion | ▼ -49.0% |
| 2015 | 1.05x | ₩7.66 Billion | ₩7.33 Billion | ▲ +81.5% |
| 2014 | 0.58x | ₩3.83 Billion | ₩6.65 Billion | ▲ +181.4% |
| 2013 | 0.20x | ₩1.89 Billion | ₩9.23 Billion | ▼ -49.4% |
| 2012 | 0.40x | ₩2.33 Billion | ₩5.76 Billion | — |